Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhengzhou Revo-Gene Technology is a Chinese biotechnology company specializing in the development of advanced molecular diagnostic solutions for point-of-care testing (POCT). The company focuses on integrated nucleic acid analysis systems that combine sample preparation, amplification, and detection into a single, automated workflow. Their flagship RV-100 platform utilizes microfluidic technology to deliver rapid and accurate results for a variety of infectious diseases, including respiratory and gastrointestinal pathogens. Revo-Gene serves clinical laboratories, hospitals, and primary care settings, aiming to decentralize high-quality molecular diagnostics. The company also extends its technology to applications in food safety and veterinary medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengzhou Revo-Gene Technology.